EDGAR Filing Documents for 0000921895-22-000169

Form SC 13G - Statement of acquisition of beneficial ownership by individuals:

SEC Accession No. 0000921895-22-000169

Filing Date

2022-01-18

Accepted

2022-01-18 17:18:21

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	THE SCHEDULE 13G	sc13g07422010_01182022.htm	SC 13G	275159
2	JOINT FILING AGREEMENT	ex991to13g07422010_01182022.htm	EX-99.1	8403
	Complete submission text file	0000921895-22-000169.txt		285212

Mailing Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104

Business Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104 3125066500

BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice

Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080

Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412

SUTRO BIOPHARMA, INC. (Subject) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90656 | Film No.: 22535981
SIC: 2836 Biological Products, (No Diagnostic Substances)